Before co-founding GTSP Global, Inc. in Boise, Idaho, Steve Verschoor worked in the industrial materials and finance sectors. Steve Verschoor is the co-founder of Molecular Testing Labs (MLT), involved in novel coronavirus testing and antibody testing.
An antibody test looks for antibodies in the blood. When the body fights an infection, such as COVID-19, it produces antibodies. When a person gets vaccinated, such as a flu shot, the same process occurs. This is how a person develops immunity to a virus.
The antibody test doesn’t detect the virus. Instead, it examines how the immune system, the body’s natural defense against infection, has reacted to the infection. To conduct an antibody test, a technician will take a little amount of the blood through a finger prick. SARS-CoV-2, the virus responsible for causing COVID-19, is tested for one or both types of antibodies. Immunoglobulin M (IgM) antibodies are produced early in an infection.
About 14 days following the symptoms’ appearance, most people develop Immunoglobulin G (IgG) antibodies. They frequently remain in the blood for a long time after the infection is gone.
If the test results are positive for SARS-CoV-2 antibodies, then the person most probably had the virus. If it’s negative, the person is not infected or has not developed the antibodies in time even though they had the virus.
Steve Verschoor 